A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer

NCT00558922 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

54

Enrollment

INDUSTRY

Sponsor class

Stopped Unacceptable Neurotoxicity (2 cases)

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: AEG35156

Sponsor

Aegera Therapeutics